Literature DB >> 8434570

The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987.

P Reynolds1, L D Saunders, M E Layefsky, G F Lemp.   

Abstract

Population-based disease registries for acquired immunodeficiency syndrome (AIDS) and cancer were linked for San Francisco residents to study the pattern of AIDS-associated malignancies diagnosed during the time period 1980-1987. A total of 1,756 newly diagnosed malignancies were identified during these years among members of the AIDS cohort. Of these, 1,752 (99.7%) occurred in males, 1,454 (83%) were Kaposi's sarcoma, 235 (13%) were non-Hodgkin's lymphoma, and 16 (1%) were Hodgkin's disease. The distributions of AIDS patients with cancer differed significantly from those without cancer by race and by risk group. Malignancies known to be human immunodeficiency virus (HIV)-associated, and now diagnostic of AIDS (Kaposi's sarcoma, non-Hodgkin's lymphoma), were, as would be expected, dramatically in excess among AIDS patients. Some malignancies not traditionally thought to be HIV-associated appear to have occurred more often than expected in the study cohort. These include Hodgkin's disease, rare non-melanoma skin cancers, and cancers of the rectum, anus, and nasal cavity. Malignancies known to be HIV-associated were more likely to be diagnosed concurrent with or subsequent to first AIDS diagnosis. Conversely, malignancies not known to be HIV-associated were more likely to be diagnosed before AIDS diagnosis. Compared with the concurrent reference population of the San Francisco Bay Area, there was little or no increase in Kaposi's sarcoma over the time interval of this study. For non-Hodgkin's lymphoma, and suggestively for Hodgkin's disease, however, the temporal increase has been quite dramatic.

Entities:  

Mesh:

Year:  1993        PMID: 8434570     DOI: 10.1093/oxfordjournals.aje.a116598

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

Authors:  Robert J Biggar; Elaine S Jaffe; James J Goedert; Anil Chaturvedi; Ruth Pfeiffer; Eric A Engels
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

Review 2.  Management of AIDS-related non-Hodgkin's lymphomas.

Authors:  M J Kersten; R H Van Oers
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

Review 4.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

5.  Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis.

Authors:  Tanwei Yuan; Yuqing Hu; Xinyi Zhou; Luoyao Yang; Hui Wang; Linghua Li; Junfeng Wang; Han-Zhu Qian; Gary M Clifford; Huachun Zou
Journal:  EClinicalMedicine       Date:  2022-08-11

6.  Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study.

Authors:  S Franceschi; L Dal Maso; S Arniani; P Crosignani; M Vercelli; L Simonato; F Falcini; R Zanetti; A Barchielli; D Serraino; G Rezza
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

7.  Trends in primary cerebral lymphoma.

Authors:  J M Lutz; M P Coleman
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

8.  Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study.

Authors:  B Afessa
Journal:  BMC Pulm Med       Date:  2001       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.